Editorial: Targeting tumor vasculature to enhance cancer immunotherapy

Front Oncol. 2023 Apr 18:13:1199811. doi: 10.3389/fonc.2023.1199811. eCollection 2023.

Jieying Yang¹, Li Fu², Toshiro Shirakawa^{3

4}, Tong Xiang¹

¹ State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center, Guangzhou, China.
² Guangdong Provincial Key Laboratory of Regional Immunity and Diseases, Department of Pharmacology and Shenzhen International Cancer Centre, Shenzhen University School of Medicine, Shenzhen, China.
³ Department of Urology, Kobe University Graduate School of Medicine, Kobe, Japan.
⁴ Department of Advanced Medical Science, Kobe University Graduate School of Science, Technology and Innovation, Kobe, Japan.

No abstract available

Keywords: cancer immunotherapy; endothelial cell anergy; immunosuppressive molecules; tumor vascularization; vascular normalization.

Publication types

This work was supported by grants from the National Natural Science Foundation of China (82172795).